Title:

Conference Call to discuss GlaxoSmithKline and Regulus Therapeutics Strategic Alliance Summary

Price:$54.00
Publication Date:Apr 17, 2008
Source:Thomson StreetEvents
Company:Alnylam Pharmaceuticals
Report Type:Brief
Abstract:Edited Brief of ALNY M&A conference call or presentation, 17-Apr-08 8:00am ET
Brief Excerpt:...On ##/##/##, GlaxoSmithKline and Regulus announced a worldwide strategic alliance to discover, develop, and market novel microRNA-targeted therapeutics to treat inflammatory diseases. ...
Word Count:4208
Length:10 Pages
Ticker:ALNY
Time:8:00am ET
Related Report(s):
Format:Adobe Acrobat Adobe Acrobat
Free Sample: Click Here to Download

Enter the keyword(s) which you would like to search for within this document and click "Search"

 
Purchase Report
Price: $54.00




Thomson StreetEvents

Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool. <br/>Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

  about us contact us public company index private company index pcan widget your privacy rights terms & conditions